Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Walker, N.; Holley, J.; Naylor, C.E.; Flores-Diaz, M.; Alape-Giron, A.; Carter, G.; Carr, F.J.; Thelestam, M.; Keyte, M.; Moss, D.S.; Basak, A.K.; Miller, J.; Titball, R.W.
    identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities (2000), Arch. Biochem. Biophys., 384, 24-30.
    View publication on PubMed

Protein Variants

EC Number Protein Variants Comment Organism
3.1.4.3 D293S reduced hemolytic activity, reduced cytotoxic and myotoxic activities, reduced activity against p-nitrophenylphosphorylcholine, increased dependence on Ca2+ Clostridium perfringens
3.1.4.3 D305G reduced hemolytic activity, reduced cytotoxic and myotoxic activities, significantly increased activity against p-nitrophenylphosphorylcholine Clostridium perfringens
3.1.4.3 K330E reduced hemolytic activity, reduced cytotoxic and myotoxic activities Clostridium perfringens

Organism

EC Number Organism UniProt Comment Textmining
3.1.4.3 Clostridium perfringens
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.1.4.3 phosphatidylcholine + H2O
-
Clostridium perfringens 1,2-diacylglycerol + phosphorylcholine
-
?